NCT02841631

Brief Summary

Human Papilloma Virus (HPV) has been shown to be a cause of Head \& Neck Squamous Cell Carcinoma (HNSCC) and the majority of current studies focus on what is happening in patients with a HPV HNSCC. But there is limited investigation into HPV infection in the oropharynx of patients who do not have HNSCC. The current incidence of oral HPV infection is not known in the general population locally and there is also limited information on what particular localities within the mouth that patients' harbour HPV infection what strains are present and if there are any differences in viral load. Therefore the aim of this project is to investigate within patients that undergo tonsillectomies the rate of HPV infection in tonsils to determine the amount of HPV present within the community.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2018

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 15, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 22, 2016

Completed
1.9 years until next milestone

Study Start

First participant enrolled

July 1, 2018

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2020

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2020

Completed
Last Updated

May 3, 2019

Status Verified

May 1, 2019

Enrollment Period

2 years

First QC Date

July 15, 2016

Last Update Submit

May 1, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Rate of oral and tonsillar HPV infection in patients undergoing tonsillectomies and to investigate any links with lifestyle.

    The aim of this project is to examine the rate of oral and tonsillar HPV infection in patients undergoing tonsillectomies and to investigate any links with lifestyle.

    over the 3 years of the study

Secondary Outcomes (3)

  • Validation of a reproducible oral HPV screening method to detect HPV from saliva samples and also tonsillar tissue to investigate rates of oral HPV infection.

    over the 3 years of the study

  • Quantification and typing via quantitative PCR of detectable HPV infection from saliva and tonsillar samples to investigate any differences between samples from the same patient and also different patients.

    over the 3 years of the study

  • Examination of viral load and also expression levels of the HPV viral oncogenes (E6 and E7) from infected tissue to investigate any differences in protein expression between different patients.

    over the 3 years of the study

Study Arms (1)

Post-Tonsillectomy

Subjects undergoing tonsillectomy for non-cancer reasons including operations for: recurrent tonsillitis, asymmetric tonsils, snoring surgery or obstructive sleep apnoea.

Genetic: HPV status and typing of tissue

Interventions

HPV status and typing of tissue

Post-Tonsillectomy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing a routine tonsillectomy operation for non-cancerous reasons at the hospital will be recruited for this study.

You may qualify if:

  • All patients undergoing routine tonsillectomies who can provide consent to participate over the age of 18 years old would eligible to enter the study. They would all ready be listed for a tonsillectomy after being seen by an ENT surgeon.

You may not qualify if:

  • Patients unable to give informed consent
  • If the tonsillectomy is carried out to diagnose cancer
  • Patient chooses to decline recruitment into the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Royal Derby Hospital

Derby, Derbyshire, DE22 3NE, United Kingdom

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Oral rinse and Tonsillectomy specimens

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Lecturer

Study Record Dates

First Submitted

July 15, 2016

First Posted

July 22, 2016

Study Start

July 1, 2018

Primary Completion

July 1, 2020

Study Completion

October 1, 2020

Last Updated

May 3, 2019

Record last verified: 2019-05

Locations